These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

857 related items for PubMed ID: 27808588

  • 1. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
    Fruzzetti F, Perini D, Russo M, Bucci F, Gadducci A.
    Gynecol Endocrinol; 2017 Jan; 33(1):39-42. PubMed ID: 27808588
    [Abstract] [Full Text] [Related]

  • 2. Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study.
    Tagliaferri V, Romualdi D, Immediata V, De Cicco S, Di Florio C, Lanzone A, Guido M.
    Clin Endocrinol (Oxf); 2017 May; 86(5):725-730. PubMed ID: 28092404
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H, Xing C, Zhang J, He B.
    Reprod Health; 2021 Aug 18; 18(1):171. PubMed ID: 34407851
    [Abstract] [Full Text] [Related]

  • 4. Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Jamilian H, Jamilian M, Foroozanfard F, Afshar Ebrahimi F, Bahmani F, Asemi Z.
    J Psychosom Obstet Gynaecol; 2018 Dec 18; 39(4):307-314. PubMed ID: 28980870
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
    Zacchè MM, Caputo L, Filippis S, Zacchè G, Dindelli M, Ferrari A.
    Gynecol Endocrinol; 2009 Aug 18; 25(8):508-13. PubMed ID: 19551544
    [Abstract] [Full Text] [Related]

  • 6. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G, Cappelli V, Di Sabatino A, Massaro MG, De Leo V.
    Minerva Ginecol; 2015 Oct 18; 67(5):457-63. PubMed ID: 26491824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Molecular action of insulin-sensitizing agents].
    Kacalska O, Krzyczkowska-Sendrakowska M, Milewicz T, Zabińska-Popiela M, Bereza T, Krzysiek-Maczka G, Krzysiek J.
    Endokrynol Pol; 2005 Oct 18; 56(3):308-13. PubMed ID: 16350724
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome - A randomized controlled trial.
    Andavar M, Kamaraj R, Mahalingam Vijayakumar T, Murugesan A.
    Eur J Obstet Gynecol Reprod Biol; 2024 Sep 18; 300():6-11. PubMed ID: 38972164
    [Abstract] [Full Text] [Related]

  • 14. [Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition].
    Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U.
    Minerva Ginecol; 2012 Feb 18; 64(1):23-9. PubMed ID: 22334228
    [Abstract] [Full Text] [Related]

  • 15. Inositols in Polycystic Ovary Syndrome: An Overview on the Advances.
    Facchinetti F, Unfer V, Dewailly D, Kamenov ZA, Diamanti-Kandarakis E, Laganà AS, Nestler JE, Soulage CO, Group of 'Inositol in PCOS and Reproduction'.
    Trends Endocrinol Metab; 2020 Jun 18; 31(6):435-447. PubMed ID: 32396844
    [Abstract] [Full Text] [Related]

  • 16. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
    Tan S, Hahn S, Benson S, Dietz T, Lahner H, Moeller LC, Schmidt M, Elsenbruch S, Kimmig R, Mann K, Janssen OE.
    Eur J Endocrinol; 2007 Nov 18; 157(5):669-76. PubMed ID: 17984248
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome.
    Donà G, Sabbadin C, Fiore C, Bragadin M, Giorgino FL, Ragazzi E, Clari G, Bordin L, Armanini D.
    Eur J Endocrinol; 2012 Apr 18; 166(4):703-10. PubMed ID: 22223702
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.